Literature DB >> 9385874

Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996.

.   

Abstract

In 1997, a nongovernmental surveillance group for Creutzfeldt-Jakob disease (CJD) in Japan reported to the Ministry of Health and Welfare its analysis of a 1996 mail questionnaire survey of neurologic, psychiatric, and neuropathologic institutions throughout Japan. This analysis identified 829 patients with CJD diagnosed by physicians during January 1979-May 1996, including a large number (43 patients) who had received a cadaveric dura mater graft during a neurosurgical (42) or orthopedic (one) procedure during 1979-1991. This report presents a summary of features of these 43 cases, which indicated that at least 41 of these patients had received dura mater grafts from the same processor, and describes CJD in the most recent recipient of a dura mater graft. The findings indicate that an international outbreak of CJD associated with a single brand of dura mater grafts is larger than previously recognized and that recipients of contaminated grafts may remain at risk for CJD at least 16 years following receipt of grafts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385874

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Creutzfeldt-Jakob disease and infection control.

Authors:  L Johnston; J Conly
Journal:  Can J Infect Dis       Date:  2001-11

3.  Ethics in prion disease.

Authors:  Kendra Bechtel; Michael D Geschwind
Journal:  Prog Neurobiol       Date:  2013-07-29       Impact factor: 11.685

4.  Inactivation of prions by acidic sodium dodecyl sulfate.

Authors:  David Peretz; Surachai Supattapone; Kurt Giles; Julie Vergara; Yevgeniy Freyman; Pierre Lessard; Jiri G Safar; David V Glidden; Charles McCulloch; Hoang-Oanh B Nguyen; Michael Scott; Stephen J Dearmond; Stanley B Prusiner
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  [Hygenic measures for Creutzfeldt-Jakob disease].

Authors:  H-J Knopf
Journal:  Urologe A       Date:  2002-12-19       Impact factor: 0.639

6.  Tenon advancement and duplication technique to prevent postoperative Ahmed valve tube exposure in patients with refractory glaucoma.

Authors:  Nevbahar Tamcelik; Ahmet Ozkok; Ahmet Murat Sarıcı; Eray Atalay; Huseyin Yetik; Kivanc Gungor
Journal:  Jpn J Ophthalmol       Date:  2013-05-24       Impact factor: 2.447

Review 7.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  Update: Dura Mater Graft-Associated Creutzfeldt-Jakob Disease - Japan, 1975-2017.

Authors:  Ryusuke Ae; Tsuyoshi Hamaguchi; Yosikazu Nakamura; Masahito Yamada; Tadashi Tsukamoto; Hidehiro Mizusawa; Ermias D Belay; Lawrence B Schonberger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-09       Impact factor: 17.586

9.  Creutzfeldt-Jakob disease: A case report and differential diagnoses.

Authors:  Akash Raut; Anjila Thapa; Ashish Shrestha; Kamal Saud; Reema Rajbhandari; Shailendra Katwal
Journal:  Clin Case Rep       Date:  2022-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.